Frequent early cognitive impairment in both pediatric MS and MOGAD
Open Access
- 6 August 2026
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 32 (11) , 1168-1181
Abstract
Background: Studies on early cognitive impairment (CI) in pediatric multiple sclerosis (MS) are heterogeneous and data on pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are scarce. Objectives: To evaluate early cognitive dysfunction in both diseases and delineate disease-specific neurocognitive profiles. Methods: A cross-sectional study of children with MS and MOGAD assessed neurocognition within 2 years after disease onset using a comprehensive test battery. Test results were converted to Z -scores. CI was defined as Z -scores below −1.5 in ⩾2 domains. Children were compared by CI status and domain deficits quantified with composite Z -scores. Results: Sixty-seven participants were analyzed (MS n = 36, MOGAD n = 31). Despite normal full-scale intelligence quotient, 47% of MS children and 43% of MOGAD children (acute disseminated encephalomyelitis excluded) met criteria for CI. Domain-specific impairments were prominent in complex attention, with significantly reduced composite Z -scores (MS: −1.24, p < 0.001; MOGAD: −1.12, p = 0.019). MS children additionally showed lower scores on tasks of visuospatial processing and visual memory. Only fatigue was significantly associated with the presence of CI (PedsQL fatigue Z -score: −2.61 vs −0.75, p = 0.005). Conclusion: In both pediatric MS and MOGAD, early CI is prevalent with difficulties in complex attention. Visuospatial cognition appears to be an additional vulnerable area for children with MS.Keywords
Funding Information
- Stichting Vrienden van het Sophia
- Nationale Postcode Loterij
- MS research Stichting (project number 21-1136)
This publication has 30 references indexed in Scilit:
- Structural network disruption after optic neuritis in Myelin oligodendrocyte glycoprotein antibody associated diseaseMultiple Sclerosis and Related Disorders, 2025
- Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein‐IgG Associated Disease Compared to Multiple SclerosisBrain and Behavior, 2025
- Cognitive performance and magnetic resonance imaging in people with multiple sclerosis: A systematic review and meta-analysisMultiple Sclerosis and Related Disorders, 2024
- Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisNeuroImage: Clinical, 2024
- The Prevalence of Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-analysisNeuropsychology Review, 2024
- Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective studyJournal of Neurology, 2018
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- Information processing speed in multiple sclerosis: Relevance of default mode network dynamicsNeuroImage: Clinical, 2018
- Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI StudyHuman Brain Mapping, 2014
- Fatigue in children: reliability and validity of the Dutch PedsQLTM Multidimensional Fatigue ScaleQuality of Life Research, 2011